Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow Quality Index
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow Quality Index of 0.58x as of September 2025. Operating cash flow of CN¥9.12 Million is below net income of CN¥15.68 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of Shenzhen Bioeasy Biotechnology Co. Ltd. for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300942 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year earnings quality comparison for Shenzhen Bioeasy Biotechnology Co. Ltd.. For live market cap and the full company financial profile, see Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.87x | CN¥66.87 Million | CN¥13.74 Million | ▲ +136.0% |
| 2024 | 2.06x | CN¥34.26 Million | CN¥16.62 Million | ▲ +11.7% |
| 2022 | 1.85x | CN¥152.55 Million | CN¥82.66 Million | ▲ +70.9% |
| 2021 | 1.08x | CN¥255.42 Million | CN¥236.47 Million | ▲ +10.8% |
| 2020 | 0.97x | CN¥63.79 Million | CN¥65.45 Million | ▲ +33.8% |
| 2019 | 0.73x | CN¥67.24 Million | CN¥92.29 Million | ▼ -7.0% |
| 2018 | 0.78x | CN¥57.93 Million | CN¥73.91 Million | ▲ +30.4% |
| 2017 | 0.60x | CN¥23.60 Million | CN¥39.27 Million | ▼ -61.2% |
| 2016 | 1.55x | CN¥36.31 Million | CN¥23.42 Million | — |